Literature DB >> 15341491

2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonists.

Elfatih Elzein1, Venkata Palle, Yuzhi Wu, Tenning Maa, Dewan Zeng, Jeff Zablocki.   

Abstract

We describe the synthesis of new high affinity and selective A(3)-adenosine receptor (A(3)-AdoR) agonists. Introduction of a methyl group at the N(6)-position of the A(2A)-AdoR selective 2-pyrazolyl-adenosine analogues (Figure 2) brought about a substantial increase in the A(3)-AdoR binding affinity and selectivity. While the N(6)-desmethyl analogues 3a and 4 were inactive at the A(3)-AdoR (K(i) > 10 microM), the corresponding N(6)-methyl analogues 5 and 22 showed good binding affinity at the A(3)-AdoR (K(i) = 73 and 97 nM, respectively). Replacement of the carboxamide group in 5 with different heteroaryl groups resulted in analogues with high affinities and selectivity for the A(3)-AdoR. (2R,3S,4R)-tetrahydro-2-(hydroxymethyl)-5-(6-(methylamino)-2-(4-(pyridin-2-yl)-1H-pyrazol-1-yl)-9H-purin-9-yl)furan-3,4-diol (15, K(i) = 2 nM) displayed high selectivity for the A(3)-AdoR versus A(1)- and A(2A)-AdoRs (selectivity ratios of 1900 and >2000, respectively).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15341491     DOI: 10.1021/jm049682h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

Review 2.  Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.

Authors:  Kenneth A Jacobson; Athena M Klutz; Dilip K Tosh; Andrei A Ivanov; Delia Preti; Pier Giovanni Baraldi
Journal:  Handb Exp Pharmacol       Date:  2009

3.  Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists.

Authors:  Artem Melman; Zhan-Guo Gao; Deepmala Kumar; Tina C Wan; Elizabeth Gizewski; John A Auchampach; Kenneth A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2008-04-04       Impact factor: 2.823

4.  2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists.

Authors:  Liesbet Cosyn; Krishnan K Palaniappan; Soo-Kyung Kim; Heng T Duong; Zhan-Guo Gao; Kenneth A Jacobson; Serge Van Calenbergh
Journal:  J Med Chem       Date:  2006-12-14       Impact factor: 7.446

5.  Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor.

Authors:  Enrica Calleri; Stefania Ceruti; Gloria Cristalli; Claudia Martini; Caterina Temporini; Chiara Parravicini; Rosaria Volpini; Simona Daniele; Gabriele Caccialanza; Davide Lecca; Catia Lambertucci; Maria Letizia Trincavelli; Gabriella Marucci; Irving W Wainer; Graziella Ranghino; Piercarlo Fantucci; Maria P Abbracchio; Gabriella Massolini
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

6.  Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.

Authors:  Dilip K Tosh; Francesca Deflorian; Khai Phan; Zhan-Guo Gao; Tina C Wan; Elizabeth Gizewski; John A Auchampach; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2012-05-16       Impact factor: 7.446

Review 7.  A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.

Authors:  Kenneth A Jacobson; Stefania Merighi; Katia Varani; Pier Andrea Borea; Stefania Baraldi; Mojgan Aghazadeh Tabrizi; Romeo Romagnoli; Pier Giovanni Baraldi; Antonella Ciancetta; Dilip K Tosh; Zhan-Guo Gao; Stefania Gessi
Journal:  Med Res Rev       Date:  2017-07-06       Impact factor: 12.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.